AARTIPHARMAarti Pharmalabs Ltd.

    Aarti Pharmalabs reports death of promoter Chandrakant Gogri

    • Management change

    Aarti Pharmalabs (NSE: AARTIPHARM) reported the death of Chandrakant Vallabhaji Gogri, its Chairman Emeritus and Promoter, it said in a filing on 15 Nov 2026. He ceases to be classified as a Promoter of the company under Regulation 31A(6)(c) of the SEBI listing regulations, consequent to his death.

    Promoter status ends with his death

    Gogri died on Sunday, 15 Nov 2026. Under Regulation 31A(6)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, he ceases to be classified as a Promoter of the company.

    The company said Gogri played a pivotal role in its growth and development over the years. It placed on record its profound gratitude for his contributions and enduring legacy.

    What the change in promoter status means for Aarti Pharmalabs' shareholders

    The filing reclassifies one individual from Promoter to non-promoter. It does not give the shareholding he held or any change in the promoter group's total holding, and it does not say whether any board or management role changes or who succeeds him as Chairman Emeritus.

    At a glance

    ItemDetail
    PersonChandrakant Vallabhaji Gogri
    Position beforeChairman Emeritus and Promoter
    Date of death15 Nov 2026

    Filed with BSE on . Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Get the Blacklitt app

    Hold Aarti Pharmalabs Ltd.? See it with the rest of your portfolio

    Bring in your stocks and mutual funds once. Blacklitt sets them against a plan for your goals and risk, and tells you what to change and why.

    Fee-only SEBI Registered Investment Adviser, INA000022428. No commission from any fund house, broker or company.

    QR code: get the Blacklitt app on iPhone or Android

    Scan with your phone camera to get the app.

    Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

    Related posts

    All Aarti Pharmalabs Ltd. articles

    QR code: get the Blacklitt app on iPhone or Android
    Get the app
    Get the app